Previous 10 | Next 10 |
home / stock / ipatf / ipatf news
ImmunoPrecise Antibodies ( OTCQB:IPATF ): FY GAAP EPS of -C$0.12. More news on: ImmunoPrecise Antibodies Ltd., Earnings news and commentary, , Read more ...
ImmunoPrecise Antibodies' Annual Revenues Increase 100% to $10,926,268 Million Canada NewsWire VICTORIA, Aug. 28, 2019 VICTORIA , Aug. 28, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) today reports its financial ...
ImmunoPrecise's Wholly Owned Talem Therapeutics Announces the Creation of its Scientific Committee Canada NewsWire VICTORIA, Aug. 1, 2019 VICTORIA , Aug. 1, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB PINK: IPATF) announce...
ImmunoPrecise Antibodies Announces Immuno-oncology Discovery Collaboration with Entos Pharmaceuticals Canada NewsWire VICTORIA, July 15, 2019 VICTORIA , July 15, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF), an i...
ImmunoPrecise Guarantees Success for Customers of Their Well-Established B cell Select™ Antibody Discovery Platform Canada NewsWire VICTORIA, June 26, 2019 VICTORIA , June 26, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (O...
ImmunoPrecise Antibodies Announces an Unprecedented Onboarding of Pharma and Biotech Clients Using IPA's Proprietary High-Throughput B-Cell Select™ and DeepDisplay™ Canada NewsWire VICTORIA, May 30, 2019 The Diversified Offerings of 9 Transgenic Animal Strains...
Play Video After a successful first day to the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), day two proved to be just as exciting for the annual event. Brian Bloom, CEO of Bloom Burto...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...
On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF stock soared, up nearly 1...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPATF Stock Symbol:
OTCMKTS Market:
ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange Canada NewsWire VICTORIA, BC , Dec. 23, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (Nasdaq Global Markets: IPA), a leader in full-service, therapeu...
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year Canada NewsWire Record Quarterly Revenue of $4,754,545 and Adjusted EBITDA of $795,159 Announced Strategic Partnership ...
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate VICTORIA, BC , Dec. 14, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody discovery and development and LiteVax...